Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis

Published:2017-10-19 Issue:16 Volume:377 Page:1537-1550
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Mease Philip,Hall Stephen,FitzGerald Oliver,van der Heijde Désirée,Merola Joseph F.,Avila-Zapata Francisco,Cieślak Dorota,Graham Daniela,Wang Cunshan,Menon Sujatha,Hendrikx Thijs,Kanik Keith S.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1615975

Cited by 456 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nociplastic pain in axial spondyloarthritis and psoriatic arthritis: role of JAK kinases in immunopathology and therapeutic impact of JAK inhibitors;Expert Review of Clinical Immunology;2024-09-08

2. Treatment strategies for Spondyloarthritis: Implementation of precision medicine – Or “one size fits all” concept?;Autoimmunity Reviews;2024-09

3. Januskinaseinhibitoren für dermatologische Erkrankungen;Die Dermatologie;2024-08-30

4. Efficacy and Safety of Upadacitinib for Axial Spondyloarthritis: A Systematic Review and Meta-Analysis;Current Rheumatology Reviews;2024-08-19

5. Adherence, Persistence, Healthcare Resource Use, and Costs in Tofacitinib-Treated Patients with Psoriatic Arthritis: Data from Two United States Claims Databases;Advances in Therapy;2024-08-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP